Profile data is unavailable for this security.
About the company
Innovative Eyewear, Inc. is a developer of ChatGPT enabled smart eyewear, under the Lucyd, Nautica, Eddie Bauer and Reebok brands. The Company develops and sells smart eyeglasses and sunglasses, which are designed to allow its customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its first commercial product, Lucyd Lyte, enables the wearer to remain connected to their digital lives. Its product offering consists of 29 different models, which offers a similar amount of style variety as many traditional eyewear collections. All styles are each available with 80+ different lens types, resulting in thousands of variations of products available. The Company has over 100 licensed patents and applications. The Company’s smartglasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands-free.
- Revenue in USD (TTM)1.39m
- Net income in USD-7.20m
- Incorporated2020
- Employees11.00
- LocationInnovative Eyewear Inc11900 Biscayne Blvd, Suite 630NORTH MIAMI 33181United StatesUSA
- Phone+1 (954) 826-0329
- Fax+1 (302) 636-5454
- Websitehttps://lucyd.co/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nuwellis Inc | 8.90m | -19.93m | 5.12m | 59.00 | -- | 2.18 | -- | 0.5759 | -8.30 | -8.30 | 2.73 | 0.1304 | 0.7076 | 1.55 | 7.04 | 150,762.70 | -143.62 | -98.07 | -216.07 | -122.48 | 57.41 | 55.22 | -202.97 | -230.51 | 0.7092 | -4.75 | 0.00 | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
Vapotherm Inc | 70.07m | -54.94m | 5.23m | 182.00 | -- | -- | -- | 0.0746 | -8.62 | -8.62 | 11.00 | -11.02 | 0.8122 | 1.46 | 7.53 | 385,011.00 | -63.68 | -49.73 | -587.27 | -62.54 | 45.28 | 43.56 | -78.40 | -78.99 | 0.1259 | -1.27 | 2.59 | -- | 2.80 | 10.14 | 48.62 | -- | -10.38 | -- |
Arch Therapeutics Inc | 130.55k | -8.43m | 5.29m | 8.00 | -- | -- | -- | 40.51 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
BIOLASE Inc | 49.16m | -37.62m | 5.61m | 157.00 | -- | -- | -- | 0.1142 | -37.97 | -37.97 | 38.54 | 0.5726 | 1.34 | 2.38 | 8.68 | 313,146.50 | -56.30 | -49.28 | -115.21 | -85.80 | 34.02 | 35.27 | -41.97 | -50.72 | 0.683 | -6.61 | 0.8778 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
SINTX Technologies Inc | 2.78m | -8.88m | 5.69m | 43.00 | -- | 0.2388 | -- | 2.05 | -389.94 | -389.94 | 74.21 | 38.86 | 0.138 | 1.62 | 5.84 | 64,534.88 | -44.03 | -45.71 | -57.11 | -57.36 | 67.96 | 58.47 | -318.99 | -681.80 | 1.67 | -- | 0.0229 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
Encision Inc | 6.87m | -448.00k | 5.88m | 31.00 | -- | 2.68 | -- | 0.8568 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
Fuse Medical Inc | 18.40m | 3.63m | 6.06m | 31.00 | 2.28 | -- | 1.64 | 0.3295 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
Guided Therapeutics Inc | 82.00k | -3.23m | 6.07m | 4.00 | -- | -- | -- | 74.02 | -0.0623 | -0.0623 | 0.0016 | -0.0721 | 0.0374 | 0.0904 | 11.71 | 20,500.00 | -137.80 | -136.13 | -- | -- | 32.93 | 29.39 | -3,685.37 | -3,666.67 | 0.1138 | -11.13 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
Sonendo Inc | 40.19m | -57.74m | 6.13m | 216.00 | -- | 0.2499 | -- | 0.1525 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
Sigyn Therapeutics Inc | 0.00 | -3.56m | 6.43m | 5.00 | -- | -- | -- | -- | -3.04 | -3.04 | 0.00 | -3.28 | 0.00 | -- | -- | 0.00 | -724.37 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0199 | -1.92 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
Vivos Therapeutics Inc | 13.36m | -15.64m | 6.68m | 114.00 | -- | 9.71 | -- | 0.4999 | -11.00 | -11.00 | 8.73 | 0.2131 | 0.9247 | -- | 31.59 | 117,219.30 | -108.24 | -89.72 | -243.30 | -149.70 | 58.90 | 70.20 | -117.06 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
Nexalin Technology Inc | 158.86k | -4.94m | 6.80m | 6.00 | -- | 2.92 | -- | 42.83 | -0.6676 | -0.6676 | 0.0215 | 0.3129 | 0.0363 | 0.1778 | 44.01 | 26,476.67 | -112.76 | -- | -139.94 | -- | 82.54 | -- | -3,110.58 | -- | 4.75 | -- | 0.00 | -- | -91.62 | -- | -173.80 | -- | -- | -- |
Innovative Eyewear Inc | 1.39m | -7.20m | 7.18m | 11.00 | -- | 1.39 | -- | 5.16 | -0.6074 | -0.6074 | 0.1174 | 0.2948 | 0.2803 | 1.89 | 15.42 | 126,457.30 | -145.15 | -- | -168.75 | -- | -8.82 | -- | -517.88 | -- | 3.68 | -6,764.71 | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
Neurometrix Inc | 5.27m | -7.98m | 8.00m | 26.00 | -- | 0.4214 | -- | 1.52 | -6.32 | -6.32 | 4.20 | 9.44 | 0.2381 | 1.25 | 10.08 | 202,700.40 | -36.07 | -23.24 | -38.94 | -27.26 | 61.97 | 59.17 | -151.51 | -48.88 | 10.11 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
Sharps Technology Inc | 0.00 | -8.71m | 8.11m | 3.00 | -- | 1.18 | -- | -- | -0.6204 | -0.6204 | 0.00 | 0.4378 | 0.00 | -- | -- | -- | -74.67 | -- | -95.84 | -- | -- | -- | -- | -- | 0.492 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
Predictive Oncology Inc | 1.96m | -14.78m | 8.55m | 34.00 | -- | 2.09 | -- | 4.36 | -3.66 | -3.66 | 0.4853 | 0.9977 | 0.1099 | 1.71 | 4.95 | 57,642.65 | -82.89 | -91.80 | -108.54 | -126.29 | 64.18 | 64.64 | -754.19 | -1,419.99 | 1.35 | -- | 0.0093 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Mar 2024 | 47.23k | 0.36% |
Citadel Securities LLCas of 31 Mar 2024 | 39.88k | 0.30% |
Geode Capital Management LLCas of 31 Mar 2024 | 33.81k | 0.26% |
Two Sigma Securities LLCas of 31 Mar 2024 | 29.22k | 0.22% |
Creative Planning LLCas of 31 Mar 2024 | 16.31k | 0.12% |
Tower Research Capital LLCas of 31 Mar 2024 | 8.42k | 0.06% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 3.61k | 0.03% |
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 31 Mar 2024 | 250.00 | 0.00% |
Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 49.00 | 0.00% |
Virtu Americas LLCas of 31 Mar 2024 | 0.00 | 0.00% |